OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
September 03, 2014
Andrew Strong, president and CEO of Kalon Kalon Biotherapeutics, provided commentary on the evolving role of contract services in biologics drug development and manufacturing.
Ron Connolly, vice president of commercial operations at Frontage Labs, provided commentary on the role of contract services in analytical services.
September 02, 2014
Experts at Xcelience provided commentary on the evolving role of contract services in analytical services and solid/semi-solid development manufacturing.
The quality-by-design principles used to control process variability are equally important to measurement systems because process variability includes contributions from measurement system variability. The authors use real-life examples from drug development projects to outline how an understanding of chromatographic measurement system variability might be achieved.
Experts from Baxter BioPharma Solutions provided the following commentary on trends in bio/pharmaceutical development outsourcing.
Annual study shows geographic proximity not a factor in CMO selection.
John Sandles, Business Analyst for Fujifilm Diosynth Biotechnologies, provided commentary on the evolving role of contract services in biologics drug development and manufacturing.
September 01, 2014
Changing regulations are impacting the identification and monitoring of variable materials in excipients.
August 04, 2014
Biopharma manufacturers must reduce the risk in their complex supply chains
August 02, 2014
Annual study shows CMO technical expertise is not enough.